ENDO 2025 Abstract·23 OctMON-547 Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: A Systematic Review And Meta-analysis of Randomized Controlled TrialsReviewInterventionsPaper